Table 1.
Characteristic | N = 48 |
---|---|
Age, median (range) | 60 (27–74) |
Gender | |
Male | 34 (70.8%) |
Female | 14 (29.2%) |
Race | |
African–American | 5 (10.4%) |
Caucasian | 41 (85.4%) |
Other | 2 (4.2%) |
BMI, median [IQR] | 25.4 (21.3–28.2) |
Smoking history, pack years (PY) | |
Never smoker | 23 (47.9%) |
≤10 PY | 7 (14.6%) |
>10 PY | 17 (35.4%) |
Unknown | 1 (2.1%) |
Primary site | |
Anterior tongue | 6 (12.5%) |
Retromolar trigone | 2 (4.2%) |
Lip | 1 (2.1%) |
Oropharynx, tonsil and base of the tongue | 20 (41.7%) |
Hypopharynx | 2 (4.2%) |
Aryepiglottic fold | 1 (2.1%) |
Larynx | 5 (10.4%) |
Nasal cavities | 1 (2.1%) |
Nasopharynx | 2 (4.2%) |
Parotid gland | 3 (6.3%) |
Unknown primary | 1 (2.1%) |
Other | 4 (8.3%) |
Disease state | |
Recurrent | 40 (80.3%) |
Primary | 7 (14.6%) |
Metastatic | 1 (2.1%) |
p16 + (for oropharynx) | 14 (29.2%) |
ECOG PS | |
1 | 26 (54.2%) |
0 | 20 (40.7%) |
Unknown | 2 (4.2%) |